1. Hallek M. et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines // Blood. 2008. Vol. 111, N 12. P. 5446–5456.
2. Swerdlow S.H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms // Blood. 2016. Vol. 127, N 20. P. 2375–2390.
3. Rawstron A.C. et al. Monoclonal B lymphocytes with the characteristics of «indolent» chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts // Blood. 2002. Vol. 100, N 2. P. 635–649.
4. Ghia P. et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly // Blood. 2004. Vol. 103, N 6. P. 2337–2342.
5. Rawstron A.C. et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia // N. Engl. J. Med. 2008. Vol. 359, N 6. P. 575-583.
6. Nieto W.G. et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach // Blood. 2009. Vol. 114, N 1. P. 33–37.
7. Call T.G. et al. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines // Cancer. 2014. Vol. 120, N 13. P. 2000–2005.
8. Vogt R.F. et al. Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies // Br. J. Haematol. 2007. Vol. 139, N 5. P. 690–700.
9. Shim Y.K. et al. Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population // Cytometry B Clin. Cytom. 2007. Vol. 72, N 5. P. 344–353.
10. Landgren O. et al. B-cell clones as early markers for chronic lymphocytic leukemia // N. Engl. J. Med. 2009. Vol. 360, N 7. P. 659–667.
11. Scarfò L. et al. CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? // Semin. Cancer Biol. 2010. Vol. 20, N 6. P. 384–390.
12. Slager S.L. et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL // Blood. 2011. Vol. 117, N 6. P. 1911–1916.
13. Muscara M.J. et al. Establishing absolute lymphocyte count thresholds for further review of peripheral blood lymphocytosis to judiciously screen for monoclonal B-cell populations in older adults // Am. J. Clin. Pathol. 2019. Vol. 152, N 4. P. 458–462.
14. Rawstron A.C. et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL) // Cytometry B Clin. Cytom. 2010. Vol. 78, suppl. 1. P. S19–S23.
15. Goldin L.R. et al. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families // Br. J. Haematol. 2010. Vol. 151, N 2. P. 152–158.
16. Matos D.M. et al. Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia // Br. J. Haematol. 2009. Vol. 147, N 3. P. 339–346.
17. Crowther-Swanepoel D. et al. Inherited genetic susceptibility to monoclonal B-cell lymphocytosis // Blood. 2010. Vol. 116, N 26. P. 5957-5960.
18. Sellick G.S. et al. A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia // Blood. 2007. Vol. 110, N 9. P. 3326–3333.
19. Strati P., Shanafelt T.D. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification // Blood. 2015. Vol. 126, N 4. P. 454–462.
20. Fazi C. et al. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals // Cytometry B Clin. Cytom. 2010. Vol. 78, suppl. 1. P. S61–S68.
21. Anderson L.A., Landgren O., Engels E.A. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia // Br. J. Haematol. 2009. Vol. 147, N 4. P. 444–449.
22. Casabonne D. et al. Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults // PLoS One. 2012. Vol. 7, N 12. Article ID e52808.
23. Scarfò L., Fazi C., Ghia P. MBL versus CLL: how important is the distinction? // Hematol. Oncol. Clin. North Am. 2013. Vol. 27, N 2. P. 251–265.
24. Parikh S.A., Kay N.E., Shanafelt T.D. Monoclonal B-cell lymphocytosis: update on diagnosis, clinical outcome, and counseling // Clin. Adv. Hematol. Oncol. 2013. Vol. 11, N 11. P. 720–729.
25. Dagklis A. et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring // Blood. 2009. Vol. 114, N 1. P. 26–32.
26. Shanafelt T.D. et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia // J. Clin. Oncol. 2009. 27(24): p. 3959-63.
27. Fung S.S. et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis // Leuk. Lymphoma. 2007. Vol. 48, N 6. P. 1087–1091.
28. Fazi C. et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL // Blood. 2011. Vol. 118, N 25. P. 6618–6625.
29. Shanafelt T.D. et al. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management // Leukemia. 2010. Vol. 24, N 3. P. 512–520.
30. Shanafelt T., Hanson C.A. Monoclonal B-cell lymphocytosis: definitions and natural history // Leuk. Lymphoma. 2009. Vol. 50, N 3. P. 493–497.
31. Scarfò L. et al. Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? // Leukemia. 2012. Vol. 26, N 7. P. 1703–1707.
32. Barrio S. et al. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome // Leukemia. 2017. Vol. 31, N 1. P. 170–176.